Trial Profile
A Randomized, Double-Blinded, Placebo-Controlled, Two-Way Crossover Study to Investigate The Safety And Toleration Of Single Dose Sildenafil In Subjects Receiving Chronic UK-369,003.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 11 Dec 2009
Price :
$35
*
At a glance
- Drugs Sildenafil (Primary) ; Gisadenafil
- Indications Erectile dysfunction
- Focus Adverse reactions
- Sponsors Pfizer
- 28 Jan 2009 New trial record.